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Abstract
Urinary tract infection (UTI) is the most common infection caused by enterococci, and Enterococcus faecalis accounts for the
majority of enterococcal infections. Although a number of virulence related traits have been established, no comprehensive
genomic or transcriptomic studies have been conducted to investigate how to distinguish pathogenic from non-pathogenic
E. faecalis in their ability to cause UTI. In order to identify potential genetic traits or gene regulatory features that distinguish
pathogenic from non-pathogenic E. faecalis with respect to UTI, we have performed comparative genomic analysis, and
investigated growth capacity and transcriptome profiling in human urine in vitro. Six strains of different origins were
cultivated and all grew readily in human urine. The three strains chosen for transcriptional analysis showed an overall similar
response with respect to energy and nitrogen metabolism, stress mechanism, cell envelope modifications, and trace metal
acquisition. Our results suggest that citrate and aspartate are significant for growth of E. faecalis in human urine, and
manganese appear to be a limiting factor. The majority of virulence factors were either not differentially regulated or down-
regulated. Notably, a significant up-regulation of genes involved in biofilm formation was observed. Strains from different
origins have similar capacity to grow in human urine. The overall similar transcriptional responses between the two
pathogenic and the probiotic strain suggest that the pathogenic potential of a certain E. faecalis strain may to a great extent
be determined by presence of fitness and virulence factors, rather than the level of expression of such traits.
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Introduction
Once considered as harmless commensals of the intestinal tract,
enterococci now rank among the leading causes of infections
among hospital patients [1,2]. Enterococcus faecalis is among the
most prevalent agents isolated from nosocomial urinary tract
infections (UTIs), and is a common cause of chronic and recurrent
UTIs, especially those associated with structural abnormalities and
medical devices, such as urinary catheters [3]. The ability of E.
faecalis to cause infection has been linked to inherent enterococcal
traits, enabling the bacterium to tolerate harsh and diverse
environments. In addition, several factors that may contribute to
enterococcal virulence have been characterized (reviewed in [4]),
and the role of these factors in pathogenicity have been further
established in various animal models [5,6,7,8] and cultured cell
lines [9,10]. However, a widespread distribution of putative
virulence determinants in enterococcal isolates independent of
origin has been reported [11,12,13,14,15,16], and to date, no
single virulence factor has been demonstrated to be essential for
enterococcal infections. The ability of E. faecalis to cause infection
is therefore likely to involve an orchestrated interplay between the
regulation of these putative virulence factors and various genetic
determinants that govern adaptation of the bacterial cell
physiology during the infection process. Cultivation in urine
partly mimics the urinary tract environment, and identification of
differentially expressed genes in vitro may therefore represent a
potential means to identify novel fitness factors required for this
particular ecological niche.
ShepardandGilmore previously examined the effectof growthin
urine on the expression of known and suspected enterococcal
virulence factors by quantitative real-time PCR [17], and significant
changes in E. faecalis virulence-associated gene expression were
observed in response to the biological cues present in urine,
compared to laboratory medium-growth. Furthermore, studies of
other pathogens causing UTI have reported responses involving
iron acquisition systems and genes involved in sugar and amino acid
metabolism [18,19], which may indicate that bacteria suffer from
glucose and iron limitation during growth in human urine.
In this report, we compare the global expression profiles of three
E. faecalis strains during growth in human urine in vitro. The three
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12489strains were chosen based on their origins; the Symbioflor 1 strain,
included in a commercial probiotic product used for more than fifty
years without any reports of infection [20], the hospital outbreak
strain MMH594 holding most known virulence genes in its genetic
repertoire [21,22], and finally the laboratory strain OG1RF which
harbors someimportant virulence traits likefsr and epa, butis devoid
of mobile genetic elements (MGEs) [23,24]. This latter strain is
however capable of causing infection in e.g. mice [23,25], and has
been extensively used as a model organism to investigate virulence
([4] and references therein). The aim of this work was to gain insight
into genetic factors that make E. faecalis such a potent cause of
human UTI. The study was designed to identify traits that
distinguish pathogenic from non-pathogenic E. faecalis. Identifica-
tion of such traits may ultimately contribute to development of
strategies for prevention and treatment of E. faecalis UTI.
Results and Discussion
Growth capacity of different E. faecalis strains in urine
and 2xYT
Escherichia coli associated with UTI normally grow well in urine,
while non-uropathogenic strains do not [26]. To examine whether
this also could be true for E. faecalis, six strains of nosocomial, UTI,
commensal or probiotic origin were cultivated in urine and colony
forming unit (CFU) counts performed (Figure 1). Only minor
differences in growth capacity were observed between the various
isolates, with generation times of around 48 minutes (doubling
time of 48.663.7 min). MMH594 and V583 reached a slightly
higher final cell density (,2.0610
8 CFU/ml) compared to
OG1RF and Symbioflor 1 (,1.2610
8 CFU/ml), and even more
so compared to Baby isolate 62 and 179Vet (,6.5610
7 CFU/ml).
These observations are consistent with a recent study by Carlos
et al. [27], where strains from diverse origins, such as food and
clinical strains, did not grow significantly different in urine.
Furthermore, the growth capacity of MMH594 observed in the
present study was in agreement with previous reports [17].
Since the initial growth experiments did not reveal any strains
with a distinctively enhanced or reduced growth capacity in urine,
two pathogenic strains MMH594 and OG1RF, and the probiotic
strain Symbioflor 1 were selected for further investigation by
comparative genomic analysis and transcriptional analysis.
Comparative genomic analysis
A comparative genomic analysis was conducted with emphasis
on features that distinguish the three strains. The genomes of the
strains used in the present study have previously been analyzed,
and many aspects of the genomic composition have thus been
accounted for (MMH594: [22,28]; OG1RF: [23,29]; Symbioflor
1: [20]. However, there are no sequence data publicly available for
the Symbioflor 1 strain. Moreover, there existed no publicly
available complete annotation for OG1RF. Thus, in order to
obtain a detailed account of genetic variation and to validate the
performance of our microarray, CGH was performed on the three
strains (Figure 2, Figure 3 and Table S1). A total of 2284 genes
were classified as present in all the strains tested. Not surprisingly,
the clinical bacteremia isolate MMH594 showed the highest
similarity to the reference strain V583 (94.7% genes in common).
The presence of the entire pathogenicity island (PAI) in MMH594
was also confirmed [22,30]. For the two other test stains the
similarity to the reference strain was significantly lower, with 2384
(74.1%) and 2371 (73.7%) of V583 genes represented on the array
classified as present in OG1RF and Symbioflor 1, respectively.
Altogether, MMH594 contains 596 genes that appear to be
divergent in OG1RF and Symbioflor 1. Major variations in the
presence of all the previously defined mobile genetic elements
(MGEs) [28,31] were observed between the three test strains.
Except for phage01 and vanB, all the MGEs seemed to be present in
MMH594. phage02 appear to be part of the E. faecalis core genome,
while none of the other elements were found in OG1RF. This
observation is consistent with the genome sequence available for
OG1RF [23]. Symbioflor 1 contained certain genes/modules from
phage06, but not the entire element. The rest of the MGEs were
Figure 1. Growth of E. faecalis in urine. Characterization of growth of E. faecalis MMH594 (black circle), OG1RF (red triangle), Symbioflor 1 (green
square), Baby isolate 62 (yellow diamond), V583 (blue triangle) and 179Vet (pink hexagon) in urine. The growth curves are represented by colony
forming units per millilitre (CFU/ml) on the Y-axis, and hours as indicated on the X-axis. The growth curves correspond to the mean 6 STD of two
parallels.
doi:10.1371/journal.pone.0012489.g001
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previous reports [20]. Notably, Symbioflor 1 contains two major
deletions in proximity to the vanB associated island and the efaB5
element (Figure 3 and Table S1). The latter deletion extends in the
59 direction of efaB5 to EF1811 including the fsr-gelE-sprE
virulence locus. The number of predicted OG1RF genes (2384)
in common with V583 was significantly lower compared to 2474
genes identified in a previous report [23]. This instigated us to
perform a more detailed analysis to identify the cause of this
discrepancy. For this purpose we performed BLASTN comparison
to V583 of 2558 genes (Table S2) predicted using EasyGene 1.2
[32], which showed an overall identity (,96.5%) between the
CGH and the BLASTN analysis. An interactive Genewiz map
[33] of OG1RF CGH and BLASTN (Genbank ABPI00000000)
analysis compared with V583 is accessible at; http://ws.cbs.dtu.
dk/cgi-bin/gwBrowser-0.91/edit.cgi?hexkey=6561d07e713b77fe
75aa3403798e36c1. Moreover, BLASTN comparison of the
annotated genes of V583 with the OG1RF genome sequence
using 75% sequence identity across an entire CDS (Table S3)
identified 2385 orthologous genes, confirming the results
obtained by CGH and EasyGene 1.2 analysis.
Transcriptional analysis
A rich laboratory medium (2xYT) was used as the reference
culture medium since it is considered to contain a minimum of
infection relevant biological cues [17]. The growth capacity in
urine was compared to that in the 2xYT medium by CFU counts
(Figure S1). We found that growth in urine was slightly slower, and
the cell density obtained was about one log lower than in 2xYT.
For the transcriptional analysis, the three strains were grown in
2xYT to a cell density ,1610
7 before exposure to either pre-
warmed urine or 2xYT (control). Samples were collected after 5
(t5) and 30 (t30) minutes growth. The obtained log2-ratios and q-
values for the three strains during growth in urine compared to
2xYT are listed in Table S1.
Growth in urine vs. 2xYT triggers global transcriptional
changes for both pathogenic and probiotic E. faecalis
The microarray results revealed changed expression in most
functional gene categories for all three strains. At t5, 713 genes
were differentially expressed in MMH594, 735 in OG1RF and
730 in Symbioflor 1. 344 of these regulated genes were common
for all three strains (Figure 4A). At t30, the number of regulated
genes increased dramatically to 1212 genes in MMH594 and 979
in Symbioflor 1. However, in OG1RF the number of regulated
genes decreased to 574 after 30 minutes growth in urine. It is
possible that the reduced number of regulated genes in OG1RF at
t30 reflects a more rapid adjustment to the new growth
environment, which potentially can be advantageous for the
establishment of an infection. This notion was further supported
by the swift derepression of macromolecular biosynthesis (e.g.
protein synthesis) in OG1RF, compared to the two other strains. A
total of 378 differentially expressed genes were common for
MMH594, OG1RF and Symbioflor 1 at t30 (Figure 4B). Of the
596 genes that appeared unique to MMH594, 153 were
differentially expressed at one or both time points during growth
in urine. None of the genes unique to OG1RF or Symbioflor 1
were differentially expressed. The heat map in Figure 5 presents
an overview of the regulated genes within each functional category
for the three strains. An overview of the number of regulated genes
within each functional category is given in Figure S2.
Transcription of metabolic pathways during growth in
urine
Prior to the current study, no comprehensive investigation
regarding which substrates or metabolic processes that confer
growth of E. faecalis in urine existed. The transcriptome data
(Table S1) was thus examined to identify metabolic pathways that
showed specific responses during growth in urine.
With respect to carbon metabolism the genes encoding the main
glucose uptake-system, mannose phosphoenolpyruvate phospho-
transferase (PTS) mptBACD (EF0019-22) [34] were down-regulated
in all three strains at t30. This is consistent with a recent
metabolomic investigation which showed that urine from healthy
adults contains glucose concentrations in the range of 0.2–0.6 mM
[35]. Such concentrations of glucose is below the threshold for
release of carbon catabolite repression (CCR), and the cells thus
initiate use of less preferred carbon and energy sources [36]. This
implied that substrates besides glucose might play a role for growth
of E. faecalis in urine. However, of the loci known to be subject to
catabolite control protein A (CcpA) mediated CCR, only the genes
encoding citrate metabolism (EF3322-15) [37] were positively
modulated in MMH594 and OG1RF at both time points and at t5
in Symbioflor1. At t30 EF3322-15 only showed a slightly (not
statistically significant) enhanced expression in Symbioflor 1. The
content of citrate in human urine is in the range of 1–2 mM [38],
which suggests that citrate metabolism is important for E. faecalis
during growth in urine.
PTS systems facilitate uptake of diverse sugars in E. faecalis. Two
operons encoding a sucrose uptake PTS-system (EF1602-01) and
sucrose metabolism (EF1603-04) showed consistent up-regulation
in all three strains. Dietary sucrose is normally degraded in the
intestinal lumen and absorbed as glucose and fructose, but a
previous study has shown that even healthy individuals have mM
sucrose content in their urine [39]. Moreover, the sugar content in
urine increases with high sugar diet. Once sucrose is present in the
bloodstream it is not metabolized further, but removed from the
blood via the renal capillaries and excreted into the urine,
reaching concentrations of 70 to 200 mM [39]. Interestingly,
EF1603-04 knock-out mutants show reduced virulence in a
Caenorhabditis elegans infection model [40,41]. All three strains
showed elevated expression of the major facilitator family
transporter (EF0082) proposed to function in import of phosphor-
ylated sugars [42] and glycerol [43], which implies that such
substrates might contribute to growth in urine.
Figure 2. Gene content of E. faecalis MMH594, OG1RF and
Symbioflor 1. Venn diagram showing the distribution of genes
classified as present in the three test strains. The percentages indicated
for each strain specify how large part of total probe set represented on
the array that was classified as present in the corresponding strain.
doi:10.1371/journal.pone.0012489.g002
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bacteriuria strain revealed an important role of amino sugar and
amino acids present in urine as growth substrates [44]. The
transcription of nagB (EF0466) and nagA-1 (EF1317) involved in N-
acetyl glucosamine metabolism was elevated, implying that these
substrates were utilized by E. faecalis during growth in urine. A
massive down-regulation of glmS (EF2151), which is responsible for
conversion of fructose-6P into glucosamine-6P using glutamine as
a nitrogen source, could signify glutamine constraints.
G r o w t hi nu r i n ea l s oh a da ni m p a c to np y r u v a t em e t a b o l i c
pathways and certain changes were strain specific. For OG1RF
and Symbioflor 1, we observed increased expression of L-
lactate dehydrogenase (ldh-1; EF0255), whereas expression of
adhE (EF0900), involved in ethanol formation was reduced.
The pflAB (EF1612 and EF1613) genes responsible for formate
formation were reduced in MMH594 and Symbioflor 1 at t30.
In all strains the lutABC operon (EF1108-1110), involved in
metabolism of L-lactate like substrates was up-regulated. The
pyruvate dehydrogenase complex gene-cluster pdhAB, aceF and
lpdA (EF1353-56) involved in acetyl-CoA biosynthesis showed
consistent up-regulation in all three strains at t30.M o r e o v e r ,
the ackA gene (EF1983) responsible for conversion of acetyl-
phosphate to acetate and ATP was significantly down-
regulated, perhaps as a consequence of increased acetate
production due to elevated activity of the citrate metabolism
(EF3322-15) [37]. It is thus conceivable that the increased
acetyl-CoA formation serves to supply either the FASII
biosynthesis, or the citrate metabolism.
Figure 3. Genome-atlas presentation of CGH analysis and transcriptional responses to growth (t30) in urine compared to 2xYT.
Mobile genetic elements [28,31] are indicated by brackets. From outer to inner lanes: 1) V583 annotated CDS, 2) CGH MMH594, 3) CGH Symbioflor1,
4) CGH OG1RF, 5) Urine transcriptome MMH594, 6) Urine transcriptome Symbioflor1, 7) Urine transcriptome OG1RF, 8) Intrinsic curvature, 9) Stacking
energy, 10) Position Preference, 11) Global direct repeats, 12) Global inverted repeats, 13) GC skew, 14) AT percent. Interactive Genewiz atlases of CGH
and transcriptome data are available at; http://ws.cbs.dtu.dk/cgi-bin/gwBrowser/edit.cgi?hexkey=603430a081eb5be3f306e744e94b151a, and http://
ws.cbs.dtu.dk/cgi-bin/gwBrowser/edit.cgi?hexkey=3068b894fb6b9e44d9c135a210950f52, respectively.
doi:10.1371/journal.pone.0012489.g003
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Compared to the rich 2xYT medium the growth rates were
significantly lower in urine, and moreover, the growth halted one
order of magnitude below that in 2xYT (Figure S1). For E. coli it
has been demonstrated that growth in urine is restricted by
availability of one specific cofactor, namely iron [44]. We were
thus interested to see whether the transcriptional responses with
respect to transport and biosynthesis processes in E. faecalis, could
reveal candidate nutrients or co-factors whose availability restrict
growth of E. faecalis in urine.
Human urine contains significant amounts of creatine, creati-
nine, and glycine, while other amino acids like histidine,
glutamine, methionine, proline, glutamate, arginine and branched
chain amino acids (bcaa) are present at lower concentrations [45].
The CGH-results indicate that MMH594 and Symbioflor 1 have
similar requirements for amino acids as OG1RF, which was
shown to be auxotrophic for amino acids like histidine, isoleucine,
methionine, and tryptophan [24]. Also, some E. faecalis strains
require arginine, glutamate, glycine, leucine, or valine [24], and
are capable of utilizing certain amino acids as energy and carbon
source [46,47]. However, transcription of the genes encoding
catabolism of arginine (EF0104-7 and EF0108) and serine
(EF0097-100) was significantly reduced at t30, indicating a shift
towards protein synthesis rather than energy metabolism.
According to our data, the transcription of several genes
encoding oligo-peptide ABC-transporters (EF0907, EF0909-12
and EF3110-06) was enhanced at t30, while the transcription of
three amino acid permease genes (EF0635, EF0929 and EF2377)
and two operons encoding amino acid transporters (EF0247-46
and EF0761-60) was reduced in all three strains at the same time
point (Table S1). These observations indicate that E. faecalis meets
its demand for certain amino acids by acquiring oligo-peptides
during growth in urine. However, the gln-operon encoding
glutamine/glutamate transport system (EF1120-17) [48] was up-
regulated in all strains at both time points, suggesting that
glutamate/glutamine from urine were utilized. This was further
supported by the observed reduced expression of the glutamine
synthase operon glnRA (EF2160-59) in all three strains and
glutamate synthase gltA (EF2560) in OG1RF and Symbioflor 1
at t30. On the contrary, the increased expression of cysK (EF1584)
implies that cysteine is scarce in urine, which also is in accordance
to the metabolomic analysis of human urine [45].
An operon comprising a putative amino acid ABC transporter
(EF0893-92) and a putative aspartate aminotransferase (EF0891) was
Figure 4. Distribution of differentially expressed genes during growth in urine. Venn diagram showing the number of unique and
common up- and down-regulated genes in MMH594, OG1RF and Symbioflor 1 when grown in urine compared to 2xYT after A: 5 minutes (t5) and B:
30 minutes (t30).
doi:10.1371/journal.pone.0012489.g004
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facilitate the conversion of aspartate and alpha-ketoglutarate to
oxaloacetate and glutamate, which may also in turn explain the
down-regulation of the above mentioned gltA.F u r t h e r m o r e ,t h e
transcription of a gene encoding methionine synthase (EF0395) was
enhanced in all three strains. These results are consistent with the
metabolomic analysis of human urine which showed that aspartate is
5-fold more abundant than methionine [45]. These observations
imply that aspartate might serve a keyrolefornitrogen metabolismof
E. faecalis in urine. Thus, it appears that E. faecalis scavenge available
peptides and amino acids, which in turn are sequentially hydrolyzed
and transaminated in order to fuel the pool of depleted amino acids.
Urinary tract pathogenic bacteria like E. coli (UPEC), have
pathogenic islands dedicated to acquisition of limited nutrients and
biometals [49]. Manganese is one such factor which is essential for
the fermentative metabolism of lactic acid bacteria (LAB) [50,51].
The up-regulation of the main manganese scavenging mechanism
encoded by efaCBA (EF2074-76), accompanied by two other genes
(EF1057 and EF1901) encoding Mn
2+/Fe
2+ transporters in all
strains at both time points is a clear indication that E. faecalis
scavenged manganese. The content of manganese in human urine
is in the nano molar range [52], while the optimal concentration
for E. faecalis is in the micro molar range [53]. Thus manganese
may be restrictive for the growth of E. faecalis. This in turn can
Figure 5. Heat map of CGH data and differentially expressed genes during growth in urine. Heat map visualizing the regulated genes in
MMH594 (M), Symbioflor 1 (S) and OG1RF (O) when grown in urine compared to in 2xYT. The comparative genome hybridization (CGH) results for the
respective regulated genes are shown in columns 1–3 (light blue: present gene, white: divergent gene). Genes found to be significantly regulated are
indicated by either red (up-regulated), or blue (down-regulated). Genes regulated after growth for 5 minutes (t5) in urine compared to in 2xYT are
listed in columns 4–6 and after 30 minutes (t30) in columns 7–9. The functional categories are sorted alphabetically (column 10). Significantly
regulated hypothetical genes and genes encoding proteins with unknown function are not included in this heat map.
doi:10.1371/journal.pone.0012489.g005
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shown to be implicated in virulence [54]. Notably, for MMH594 a
potential auxiliary Mn-uptake system (EF 0575-78) [55], located
within the PAI also showed highly elevated expression, indicating
that PAI harboring strains might be better equipped to cope with
manganese depleted environments.
In addition to the above mentioned Mn
2+/Fe
2+ transporters,
our experiments also revealed an enhanced expression of several
other genes involved in iron transport; the feoAB (EF0475-76) and
ceuBCD and fatB (EF3085-82) operons were up-regulated in all
strains at t30. Another gene involved in iron transport, feuA
(EF0188) was down-regulated in all strains at t5, but was up-
regulated in MMH594 and OG1RF at t30. Interestingly, a third
iron transport encoding operon (EF0191-93) was down-regulated
in all three strains at t5, while up-regulated at t30 in OG1RF only.
Iron is one of the main limiting factors for E. coli growth in urine
and the addition of iron to urine increased the maximum growth
extensively [18,19]. LAB, on the other hand comprise one of the
very few groups of bacteria for which iron is not an essential
growth factor [51]. Even so, our data suggest a potentially
important role of iron acquisition and metabolism during growth
in urine.
Stress response of E. faecalis towards exposure to urine
Proteomic analyses with systematic exposure to various stresses
have previously identified six genes encoding general stress
response proteins (GSPs) which were up-regulated in E. faecalis
by a wide variety of environmental stimuli [56]. The enhanced
expression of all the GSP-encoding genes at one or both time
points in the present study indicates that the bacterium
experienced a multitude of stress factors upon the encounter with
urine. This impression was further substantiated by the signifi-
cantly differential transcription of a large number of genes with a
proven or predicted function in other stress responses in E. faecalis
[112–120] (Table S1 and S4).
The gene encoding Gsp62 (EF0770; hypothetical protein) was
the only GSP which showed a significantly enhanced expression in
all strain at both time points. The stress- and starvation inducible
gls24 operon (EF0076-81) was significantly up-regulated at both
time points in OG1RF and Symbioflor 1, while partly up-
regulated in MMH594. Inactivation of gls24 and glsB (EF0079 and
-80, respectively) has been reported to have a pleiotrophic effect on
cell morphology and stress tolerance in E. faecalis [57]. A gls24
disruption mutant has also been shown to be highly attenuated in
animal infection models [58,59]. MMH594 contains two addi-
tional gls24-like genes within the PAI (EF0604 and PAIef0055).
Both gene were up-regulated at t30 and might possibly contribute
to the fitness of MHH594 during growth in urine.
An organic hydroperoxide resistance protein, ohr (Gsp65;
EF0453) was up-regulated in MMH594 at t5, and in all three
strains at t30.A nohr mutant has previously been shown to be less
resistant to the oxidative stress generated by 20 mM Tertiary-
Butylhydroperoxide, suggesting that Ohr may be implicated in
oxidative stress resistance in E. faecalis [60]. Interestingly, the
microarray data revealed differentially expression of an arsenal of
genes holding putative roles in oxidative stress response in E.
faecalis (Table S1 and S4). The enhanced transcription of genes
involved in oxidative stress response during exposure to urine is
interesting. Especially in light of an observed adaptation to lethal
challenges of H2O2 by pretreatment with sublethal concentrations
of H2O2 [61], and a reported link between oxidative stress
response and survival within macrophages in enterococci
[62,63,64]. Furthermore, it has been demonstrated that purified
lipoteichoic acids from E. faecalis induced proliferation and
production of nitrous oxides and cytokines by a subpopulation of
basal urothelial cells [65,66]. It is thus tempting to speculate that
urine act as a cue to trigger oxidative stress-protection by E.
faecalis, in order to render increased resistance against certain host
defense mechanisms in the urinary tract.
Modifications to the cell envelope caused by growth in
urine
When infecting a host, the integrity and composition of the cell
envelope of the bacterium are important to avoid damage by the
host defense systems [67,68]. In the case of E. faecalis, it has been
demonstrated that important processes in the interaction with the
host e.g. recognition by immune system mechanisms and innate
immune evasion, involve specific cell envelope structures like
lipotechioc acids [69], and cell wall and capsular polysaccharide
determinants [70,71].
During growth in urine, signs of adaptation to this new growth
environment were evident for several genes important for the cell
membrane composition and surface related structures (Table S1).
We observed an immediate response to urine by the up-regulation
of two gene clusters (EF0282-84 and EF2886-75) responsible for
type II fatty acid biosynthesis (FASII) and isomerization of
membrane phospholipids. Most of these genes were up-regulated
in all strains at t5 and t30. Interestingly, these gene clusters have
previously been shown to be up-regulated in response to growth in
blood [72] and to exposure to the cell membrane detergent SDS
[73]. Furthermore, the FASII genes were down-regulated in
response to exposure to NaCl (Solheim, unpublished data), bovine
bile, and SDS and bovine bile in combination [73], indicating that
several different external stressors triggers remodeling of the fatty
acid composition in the cell membrane.
In addition to the FASII pathway, a regulation of three genes
encoding lipases (EF0169, EF1683 and EF3191) and two genes
encoding cardiolipin synthetases (EF0631 and EF1608) further
indicates both degradation and processing of fatty acids (Table S1).
It is possible that the lipolytic activity is connected to a modulation
of the FASII genes, as it recently was demonstrated that E. faecalis
can utilize available fatty acids from the environment in their
membrane biogenesis [74]. However, there are only trace amounts
of free fatty acids in urine [38], and it is therefore more likely that
the remodeling of the fatty acid composition in the cell membrane
is a more general stress response in E. faecalis, while the lipases may
play a more specialized role in virulence. A recent study by
Walecka and co-workers revealed that a higher percentage of
invasive E. faecalis isolates produce lipases compared to non-
invasive isolates [75], indicating a central role for lipase activity
during invasive infection. Notably, Symbioflor 1 showed a more
enhanced expression of genes encoding lipases compared to the
pathogenic strains.
The ability of E. faecalis to adhere and develop biofilm is thought
to be important for its potential to cause UTI and other infections
[76]. In our experimental design, the cells were cultivated
planktonically. We were thus interested in assessing whether genes
implicated in adherence or biofilm formation would be modulated
by human urine. The gene encoding the maltose PTS system malT
(EF0958) and the cognate operon bopABCD/malPBMR (EF0957-
54), are involved in biofilm formation [77,78], and were partly up-
regulated in OG1RF at t5. Another gene important for biofilm
production and the initial attachment stage for binding to abiotic
surfaces is a sortase A encoding gene, srtA (EF3056) [79,80]. This
gene showed an enhanced expression in MMH594 at t30 and
Symbioflor 1 at both time points. Interestingly, an srtA mutant
showed a slightly attenuated virulence during UTI in mice [81].
However, among the genes encoding potential substrate proteins
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EF3314 showed an enhanced expression in Symbioflor 1 at both t5
and t30. This latter gene encodes a protein recently shown to be
important for the pathogenicity of E. faecalis [82], and it is
noteworthy that the only strain which showed an enhanced
expression of this gene, was the probiotic strain.
Mohamed et al. [83] demonstrated that a knockout mutant of
the secreted antigen salB (EF0394) in OG1RF showed reduced
biofilm formation in BHI, but enhanced biofilm production in the
presence of serum or fibronectin. The authors also showed that the
salB mutant was able to bind to the extra cellular matrix (ECM)
proteins collagen type I and fibronectin, whereas wild type
OG1RF did not bind these ECM proteins [83]. Furthermore, they
showed that a salA (EF3060; secreted lipase) mutant also produced
slightly less biofilm than wild type OG1RF, while binding to ECM
was unaffected. During growth in urine salA was down-regulated
in all strains at both time points, while salB was down-regulated in
all strains at t5, and in MMH594 at t30. Mohamed and co-workers
[83] speculated that under certain conditions a down-regulation of
salB would be sufficient to see similar effects as was seen for the
salB mutant, thus it is possible that the expression of salB and
possibly also salA is reduced in response to urine in order to
promote colonization of the urinary tract.
At t5, a gene encoding the major autolysin of E. faecalis, atlA
(EF0799) was down-regulated in all three strains. An atlA deletion
mutant of OG1RF showed delayed biofilm formation, reduced
attachment on plastic surfaces and longer chains than the wild
type OG1RF [79,84]. AtlA is also essential for DNA release and
biofilm accumulation, which is needed for the development of a
mature biofilm in E. faecalis [79,85]. MMH594 and Symbioflor 1
contain a second peptidoglycan hydrolase encoding gene atlB
(EF0355), which have been shown to compensate for the absence
of AtlA in autolysis and cell separation [84]. atlB was down-
regulated at t30 in MMH594, while not differentially expressed in
Symbioflor 1. The lowered expression of atlA and atlB may also be
connected to reduced cell wall synthesis indicated by down
regulation of several genes responsible for peptidoglycan biosyn-
thesis (Table S1), which again is consistent with the significantly
lower growth rate in urine compared to 2xYT.
Bacterial surface proteins are key players in host-pathogen
interactions [81]. Therefore, the change of membrane bound
proteins might alter the bacterium’s potential of causing an
infection. Regulation of several genes encoding proteins bound to
the cell membrane or cell surface i.e. membrane proteins and
lipoproteins was observed for all three strains (Table S1).
Moreover, most microbial surface components recognizing
adhesive matrix molecules (MSCRAMMs) and cell-wall anchor
family proteins [86] including the endocarditis- and biofilm-
associated pilus (ebp) [87,88] were either down-regulated, or not
differential regulated (Table S1).
A gene encoding a chitin binding protein (EF0362) and one
encoding a chitinase (EF0361) were up-regulated in all three
strains at t5. The direct function for these genes in response to
urine is not clear, however a homologous protein GbpA in Vibrio
cholerae was shown to facilitate binding to the chitin monomer N-
acetylglucosamine [89], a sugar residue found on the surface of
epithelial cells [90,91,92], which line the cavities and surfaces of
structures including the urinary tract. Hence, it is possible that
biological cues in urine trigger the up-regulation of these genes as
an initial step of adherence to uroepithelial cells. Interestingly,
growth of E. faecalis V583 in blood triggered an even more
enhanced transcription of these two genes [72], but a functional
study of these genes would be required to elucidate any function
related to enterococcal virulence.
Most of the genes within a cluster responsible for the production
of a serotype-determining exopolysaccharide (EF2198-2177; epa)
[93,94] were down-regulated both at t5 and t30 in the three strains.
An OG1RF DepaB mutant has previously been reported to show
reduced virulence in mice [95], higher susceptibility to phagocytic
killing [71], and decreased biofilm formation compared to the wild
type [71,96]. Furthermore, Singh et al. recently showed that the
epaB mutant was less competitive compared to the wild type in a
model of UTI in mouse [97]. However, it is possible that the
exopolysaccharide production is body-site dependent, and could
be more pronounced in E. faecalis that have reached the
glomerular basement membrane in kidneys, which is a preferred
site for E. faecalis colonization [97,98].
The serotype 2 capsular polysaccharide (cps) [99], which
constitutes an important virulence factor that enables E. faecalis
to evade phagocytic killing, by masking the lipoteichoic acids [70],
is absent in both OG1RF and Symbioflor 1 (Figure 3 and Table
S1). Intriguingly, the cps gene cluster (EF2495-85) was down-
regulated in MMH594 at t30, which is similar to the response
observed in V583 growing in blood [72]. It is tempting to
speculate that a basal capsular polysaccharide production could be
sufficient to protect E. faecalis from complement-mediated
opsonophagocytosis, especially in infected tissues where micro-
colonies or biofilm develop.
In sum, the human urine milieu appears to instigate a drastically
altered composition of the cell envelope and cell surface structures,
some of which might be advantageous or required for establish-
ment of E. faecalis UTI.
Virulence traits and Regulatory genes
A number of genetic traits have been identified to contribute to
virulence in E. faecalis [5,6,8,25,59,71,99,100,101,121,122]. The
expression of selected virulence genes in MMH594 during growth
in urine have previously been examined by real-time quantitative
PCR (QPCR) [17]. More recently, a new QPCR study of the
expression in several strains including MMH594 during growth in
urine was published [102]. The two studies show some differences
in gene expression in MMH594, e.g. of a gene encoding the
enterococcal surface protein Esp (PAIef0056). Shepard and
Gilmore [17] found an enhanced expression of esp, while Carlos
et al. [102] found a reduced expression of the same gene. In the
present study, we found that the esp gene was not significantly
differentially expressed. Indeed, QPCR appear to be more
sensitive and have a broader detection range than microarray,
but the deviating results still seem to imply a problem when
comparing these types of experiments. Shepard and Gilmore [17]
reported a growth-phase dependent difference in the expression of
the virulence genes tested. Hence, the differences observed
between these three similar experiments are most likely due to
the different methods used for cultivation. Our aim was to
investigate the immediate effect on actively growing E. faecalis cells
upon the first encounter of urine. We revealed a significant impact
on the transcription of a number of virulence related traits
connected to stress, co-factor acquisition, and cell surface
structures (described above), and a summary of these genes can
be found in Table S5.
The fsr quorum sensing system has been shown to coordinate
expression of the virulence factors gelE (encoding a gelatinase) and
sprE (encoding a serine protease) during infection of C. elegans and
in mouse peritonitis models [25,101], and several other genes were
differentially expressed in wild type OG1RF compared to an fsrB
mutant, indicating a more complex regulatory network [103].
Consistent with previous observations [17], we detected a modest
up-regulation of the fsrABC genes (EF1822-20) in MMH594 at t30.
E. faecalis Urine Transcriptome
PLoS ONE | www.plosone.org 8 August 2010 | Volume 5 | Issue 8 | e12489The fsrA gene was also up-regulated at t5. In addition, the
downstream gelE (EF1818) was down-regulated at t5 in MMH594.
No regulation of these genes was observed in OG1RF (the genes
are divergent in Symbioflor 1). However, due to the fact that
several of the fsr-genes had been excluded from the data analysis as
a result of the number of functional spots in the latter strain (see
Materials and methods), the expression of fsrB was verified by real
time quantitative PCR (QPCR; Figure S3). The QPCR analysis of
fsrB revealed that the log2-ratio was below the threshold for
significant differential expression in MMH594. Differential
expression of fsrB was however, observed in OG1RF. These
results are in line with previous findings which suggest that growth
in urine promotes transcription of the fsr-quorum sensing system
[17]. Quorum sensing regulatory cascades are characteristically
initiated by elevated expression of a regulatory unit, in this case the
fsr-operon, of which the most likely consequence would be the
subsequent induction of the fsr-regulon.
The PAI is significantly more prevalent among infection-derived
isolates compared to E. faecalis from other sources [22,28,30,104].
Moreover, the contribution of PAI-related genes to the pathoge-
nicity of E. faecalis has been experimentally determined for certain
traits, such as araC, cytolysin, esp [5,100,105]. In the genome of the
three strains used in this study only MMH594 contains the entire
enterococcal PAI (129 genes, of which 125 were represented on
the array). Fifteen PAI genes were down-regulated, while twenty
PAI genes including manganese transporter (EF0575-77), gls24
(EF0604) and a bile salt hydrolase (BSH; EF0521) were up-
regulated in MMH594 at t30. The latter gene was also the only
PAI gene which showed an enhanced expression in Symbioflor 1.
The BSH and the Gls24 starvation-inducible protein are factors
that have been hypothesized to be advantageous in colonization of
the gastrointestinal tract, and our results demonstrate that
potential virulence-, stress- and fitness-genes located in the PAI
do in fact respond to an infection-relevant milieu like urine.
However, the exact function of these genes in the pathogenicity of
E. faecalis remains to be elucidated. Moreover, transcripts were
detected for a substantial number of PAI genes, implying that their
mere presence and basal expression might also be important
during UTI.
In conclusion, a significant proportion of the transcriptional
responses seen during growth in urine were common for the three
different strains examined, and the main differential regulation
was observed among genes related to stress responses, energy
metabolism, acquisition of trace metals, and a drastic modification
of the cell envelope. Despite the failure to identify pathogen-
specific E. faecalis genes, the overall similarity between the
transcriptional responses of pathogenic and non-pathogenic strains
presented here, implies that the pathogenic potential of an E.
faecalis strain may in fact be determined by presence or absence of
specific genes, rather than the level of expression of such traits.
Materials and Methods
Bacterial strains and growth conditions
Bacterial strains used in this study are listed in Table 1. The
growth capacity of six Enterococcus faecalis strains was examined.
Three of these strains were selected for transcriptional profiling
based on their origin. For all experiments E. faecalis strains were
streaked on a 2xYT agar plate (1% (w/v) yeast extract, 1.6% (w/v)
tryptone and 1% (w/v) NaCl) and incubated at 37uC over night
(ON). Four individual colonies were then inoculated into the same
tube of 5 ml 2xYT medium and grown ON without shaking at
37uC. For growth in urine, human urine was collected from four
healthy men and women who had no history of UTI or antibiotic
use in the last 6 months. The urine was pooled with equal amounts
from each volunteer, centrifuged at 120006g and sterilized twice by
filtration(0.22 mm-poresize). Since the composition ofhuman urine
may potentially be variable, samples were collected on three
separate days for three replicate experiments and used within the
next day.
Growth measurement
The six E. faecalis strains were pre-cultured as described above.
ON cultures were diluted 10006in either preheated urine (37uC)
or in preheated 2xYT medium and incubated ON. These cultures
were then diluted 10006in either preheated urine or 2xYT, and
cell growth was measured spectrophotometrically with a Bioscreen
instrument (Bioscreen C) and by plating and colony forming units
(cfu) counts. Growth experiments measured spectrophotometri-
cally were performed in triplicates with a total volume of 300 mlo f
bacterial inoculum in fresh urine or 2xYT medium. Wells
containing sterile urine/2xYT were used as negative controls.
Cultures were incubated at 37uC and optical density 600 nm
(OD600) was measured at 15-min intervals for 24 hours. To
determine CFU/ml, viable cell counts were performed as follows:
ON cultures were inoculated (10006dilution) in preheated urine.
Samples were collected immediately after inoculation, and after 2,
4, 6, 8, 10 and 24 hours for 2xYT, and also after 15 hours for
urine. The number of CFU/ml was estimated by averaging the
colony count values in two replicates per strain after ON
incubation at 37uC.
Table 1. Bacterial strains used in this study.
Strain Country Source Isolation site MLST Characteristics Reference
CC ST
Baby isolate 62 Norway Non-hospitalized person ,1 year Feces S 66 Tet
R [106]
MMH594 USA Hospitalized patient Blood 6 6 Ery
R,Gen
R, hospital outbreak [21]
OG1RF USA Laboratory strain 21 1 Rif
R,F u s
R [24]
Symbioflor 1 Germany Non-hospitalized person Feces 25 248 Probiotic [20]
V583 USA Hospitalized patient Blood 6 6 Ery
R,G e n
R,V a n
R [123]
179Vet Norway Animal_dog Urine 9 9 Multi-resistant* [29]
CC= clonal complex; Ery= erythromycin; Fus= fusidic acid; Gen= gentamicin; MLST= multilocus sequence typing; R= resistance; Rif= rifampicin; S= singleton; ST=
sequence type; Tet= tetracycline; Van= vancomycin.
*Tested against 16 different antibiotics, of which it was susceptible only to ampicillin.
doi:10.1371/journal.pone.0012489.t001
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The three selected E. faecalis strains, MMH594, OG1RF and
Symbioflor 1 were pre-cultured as described above. The cultures
were then diluted 10006 in 250 ml pre-warmed 2xYT medium
and incubated further at 37uC. When the culture reached
OD600=0.1 the cultures from each strain was split in two and
centrifuged (100006g for 3 min at 37uC). For the control cultures
the pellets were resuspended in 100 ml pre-warmed 2xYT (37uC)
whereas for the test culture the pellet was resuspended in 100 ml
pre-warmed urine (37uC). Samples (45 ml) of each culture were
collected immediately after the resuspension in urine (t5), and after
30 min (t30) by centrifugation (80006g for 2 min at 37uC), and the
pellets were immediately frozen in liquid nitrogen and kept at
280uC prior to RNA extraction.
RNA isolation, cDNA synthesis, fluorescent labeling and
hybridization
Total RNA was isolated by FastPrep (Bio 101/Savant) and
RNeasy Mini kit (QIAGEN) as previously described [72]. The
concentrations of the RNA samples were measured by using the
NanoDrop (NanoDrop Technologies), and the quality was
assessed by using the RNA 600 Nano LabChip kit and the
Bioanalyzer 2100 (Agilent Technologies). cDNA was synthesized
and labeled with the Fairplay III Microarray labeling kit
(Stratagene) according to the manufacturer’s protocol, with the
following modifications: For each labeling reaction, 10 mg of total
RNA and 500 ng of random primers were initially preheated at
70uC for 10 min. A reverse transcription-PCR mixture (106
AffinityScript RT buffer, a 206 deoxynucleoside triphosphate
mixture, 0.1 M dithiothreitol, 20 U RNase block, and Affinity-
Script HC RT) was added to the annealed primers and RNA, and
the reaction mixture was further incubated for 3 h at 42uC. After
labeling, 1 mL of hydroxylamine (Sigma Aldrich) was added to
quench the coupling reaction, and the reaction mixture was
incubated 10 min. at room temperature. 70 mL RNase-free water
was then added, and unincorporated dyes were removed from the
samples by using the QIAquick PCR purification kit (QIAGEN).
Labeled samples were then dried, prior to resuspension in 140 ml
hybridization solution (56 SSC, 0.1% (w/v) SDS, 1.0% (w/v)
bovine serum albumin, 50% (v/v) formamide and 0.01% (w/v)
single-stranded salmon sperm DNA) and hybridized for 16 h at
42uC to the array in a Tecan HS 400 pro hybridization station
(Tecan). Arrays were washed twice at 42uC with 26SSC +0.2%
SDS, and twice at 23uC with 26SSC, followed by more stringent
washes at 23uC with 0.26 SSC and with filtrated H2O. Three
replicate hybridizations were performed with three separate
batches of RNA. The three batches of RNA were obtained in
three separate growth experiments. The Cy3 and Cy5 dyes
(Amersham) used during cDNA synthesis were swapped in two of
the three replicate hybridizations. All samples in the three
experiments were co-hybridized with control samples collected
at equal time points (e.g. t5 was hybridized along with t5).
Hybridized arrays were scanned at wavelengths of 532 nm (Cy3)
and 635 nm (Cy5) with a Tecan scanner LS (Tecan). Fluorescent
intensities and spot morphologies were analyzed using GenePix
Pro 6.0 (Molecular Devices), and spots were excluded based on
slide or morphology abnormalities.
Microarrays
The microarray used in this work has been described previously
[106]. The microarray designs have been deposited in the
ArrayExpress database with the accession numbers A-MEXP-
1688 and A-MEXP-1765.
Data analysis
Downstream analysis was done by the LIMMA package (www.
bioconductor.org) in the R computing environment (www.r-
project.org). Preprocessing and normalization followed a standard
procedure using methods described by Smyth & Speed [107].
Testing for differential expressed gene was done by using a linear
mixed model as described in Smyth [108]. A mixed-model
approach was chosen to adequately describe between-array
variation and still utilize probe-replicates (3 replicates of each
probe in each array). An empirical Bayes smoothing of gene-wise
variances was conducted according to Smyth et al [109]. For each
gene, the p-value was adjusted to control the false discovery rate;
hence, all p-values displayed are FDR-adjusted (often referred to
as q-values). A gene was found to be significantly regulated if
q,0.01 and the log2-ratio was similar to or above 0.5, or similar to
or below 20.5. Genes represented with less than 1 spot on one or
more arrays were excluded from the final results (NA).
Comparative genomic hybridization
Genomic DNA was isolated by using the FP120 FastPrep bead-
beater (BIO101/Savent) and the QiaPrep MiniPrep kit (Qiagen),
as previously described [106], and then labeled and purified with
the BioPrime Array CGH Genomic labeling System (Invitrogen)
and Cyanine Smart Pack dUTP (PerkinElmer Life Sciences),
according to the manufacturer’s protocol. Standard methods in
the LIMMA package [107] in R (http://www.r-project.org/),
available from the Bioconductor (http://www.bioconductor.org)
were employed for preprocessing and normalization. Within-array
normalization was first conducted by subtracting the median from
the log-ratios for each array. A standard loess-normalization was
then performed, where smoothing was based only on spots with
abs(log-ratio) ,2.0 to avoid biases due to extreme skewness in the
log-ratio distribution. For the determination of present and
divergent genes a method that predicts sequence identity based
on array signals was used, as described by Snipen et al. [110]. A
threshold of 0.75 was used in order to obtain a categorical
response of presence or divergence, i.e. genes with Sb-value .0.75
were classified as present, while genes with Sb-value ,0.75 were
classified as divergent. Genes with Sb-value=0.75 remained
unclassified.
Microarray data accession number
The microarray data have been deposited in the ArrayExpress
database with the series accession number E-TABM-885.
OG1RF gene prediction
Gene prediction from OG1RF (Genbank ABPI00000000) was
conducted with EasyGene 1.2 [32] using model ‘‘EF02’’, with R
cut off value set at 2.
BLASTN comparison of E. faecalis V583 genes versus the
OG1RF genome
BLASTN comparison was conducted for E. faecalis V583
(Genbank AE016830) against the OG1RF genome (Genbank
ABPI00000000) as follows: the annotated V583 genes were blasted
(BLASTN) against the entire OG1RF genome, and presence and
divergence was predicted based on a score calculated as the
number of identical nucleotides divided by the length of the query
gene. Genes obtaining a score .0.75 were classified as present.
Real-time quantitative RT-PCR
Real time quantitative RT-PCR (QPCR) was used to validate
the expression levels for selected genes. QPCR was performed on
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Research). cDNA was synthesized with 1 mg total RNA as
template. In addition to the on-column DNase-treatment
mentioned above, an off-column DNase treatment was conducted
as follows: To each of the RNA preparations, 80 U RNasin, 20 U
DNase 1 and 70 ml RDD buffer was added. The reaction was
incubated at 37uC for 30 min., and DNase-treated RNA was
extracted by performing a phenol:chloroform extraction as
follows: 1:1:1 (v/v/v) phenol/chloroform/DEPC water was
added, before the samples were centrifuged at 100006g for
1 min. The aqueous layer was transferred to a tube containing
960 ml 96% ethanol and 40 ml 3M NaAc and incubated ON at
–2 0 uC, before the RNA was precipitated by centrifugation at
100006g for 30 min. at 4uC. RNA was then washed with 70%
ethanol, dried by vacuum centrifugation and resuspended in 20 ml
RNase-free water. The genes were quantified in triplicate. PCR
amplification was performed at an annealing temperature of 60uC
with 0.5 ml cDNA in a 25-ml reaction mixture containing 12.5 ml
FastStart SYBR green Master (Rox; Roche) and 0.5 mM of each
primer. The primers used are shown in Table 2. Upon completing
PCR, melting curve analysis was used to determine whether there
was detectable primer-dimer contribution to the SYBR green
fluorescence measurement of amplified DNA. Differential expres-
sion was calculated by the Pfaffl method [111]. 23S was used as a
reference.
Supporting Information
Figure S1 Characterization of growth of E. faecalis MMH594
(black circle), OG1RF (red triangle) and Symbioflor 1 (green
square) in 2xYT (stippled lines) and urine (solid lines). The growth
curves are represented by colony forming units per millilitre
(CFU/ml) on the Y-axis, and hours as indicated on the X-axis.
The growth curves correspond to the mean 6 STD of two
parallels.
Found at: doi:10.1371/journal.pone.0012489.s001 (0.10 MB TIF)
Figure S2 Distribution of differentially expressed genes in
response to urine by functional classification. Overview of the
number of up- and down-regulated genes in MMH594 (grey),
OG1RF (purple) and Symbioflor 1 (green) at A) 5 minutes and B)
30 minutes. The functional categories are listed between the two
bar-charts.
Found at: doi:10.1371/journal.pone.0012489.s002 (0.40 MB TIF)
Figure S3 The effect of urine on the expression of EF1821 (fsrB)
in MMH594 an OG1RF as quantified by QPCR.
Found at: doi:10.1371/journal.pone.0012489.s003 (5.53 MB TIF)
Table S1 Microarray expression data and comparative genome
hybridization of E. faecalis strains MMH594 (M), OG1RF (O) and
Symbioflor 1 (S). Differences in gene content were analyzed using
comparative genomic hybridization (*): present (1), divergent (0),
unclassified (U). Gene expression after 5 (t5) or 30 (t30) minutes of
growth in urine is relative to 2xYT. Significantly regulated genes
are q,0.01 (bold), and log2-ratio .60.5). "NA" denotes non-
expressed or excluded genes.
Found at: doi:10.1371/journal.pone.0012489.s004 (1.10 MB
XLS)
Table S2 Gene prediction from OG1RF (Genbank
ABPI00000000) conducted with EasyGene 1.2 [32] using model
"EF02", with R cut off value at 2. Predicted genes are presented in
nucleotide fasta format.
Found at: doi:10.1371/journal.pone.0012489.s005 (2.99 MB
TXT)
Table S3 BLASTN comparison of E. faecalis V583 genes versus
the OG1RF genome. The score was calculated as number of
identical nucleotides identified by BLAST divided by query ORF
length. ORFs obtaining a score .0.75 were classified as
orthologous genes present in the OG1RF genome.
Found at: doi:10.1371/journal.pone.0012489.s006 (0.22 MB
XLS)
Table S4 Differentially expressed genes with proven or predict-
ed function in various stress responses in E. faecalis. Only
significant log2-ratios are listed.
Found at: doi:10.1371/journal.pone.0012489.s007 (0.63 MB
DOC)
Table S5 Differentially expressed genes with proven or predict-
ed virulence function in E. faecalis. Only significant log2-ratios are
listed.
Found at: doi:10.1371/journal.pone.0012489.s008 (1.20 MB
DOC)
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